Tablets & Capsules

TC0121

Issue link: https://www.e-digitaleditions.com/i/1331851

Contents of this Issue

Navigation

Page 53 of 67

44 January/February 2021 Tablets & Capsules The batches showed low vari- ability, and therefore, good con- sistency in terms of tablet tensile strength, friability, and disintegra- tion. Variation can be expected to be even lower in non-placebo pharmaceutical formulations that would contain lower amounts of anhydrous lactose. This implies that batch-to-batch and production line-to-line variation is unlikely to cause any variation in pharma- ceutical formulations containing SuperTab 21AN. Conclusions Like APIs, excipients have been shown to introduce variability into formulations, although this variabil- ity differs between excipients and between suppliers. An intelligent use of QbD and MVA can help in the characterization and quantifica- tion of excipient variability and its impact on formulation robustness. This study demonstrates how to use PCA to de-risk the use of an excipient from two different produc- tion lines. PCA revealed its power by deviation. The maximum friability for all batches was 0.1 percent w/w. Overall, product variability from roller dryer 2 was slightly lower than product variability from roller dryer 1. This was to be expected due to the smaller knowledge space that roller dryer 2 covered in the PCA score plot, as result of the shorter production period for that roller dryer. Hausner ratio was calculated from the bulk and tapped density. Figure 7 shows a comparison of two flow- ability parameters for both roller dry- ers. Flowability did not differ signifi- cantly between the two roller dryers. The table below the figure shows the average values of FFC and Hausner ratio with a standard deviation. Figure 8 compares the tablet- ability of batches from each roller dryer. This data was obtained by evaluating tableting behavior in an extreme case to showcase max- imum difference. Blends of 95.5 percent w/w anhydrous lactose with 4 percent w/w croscarmel- lose sodium and 0.5 percent w/w magnesium stearate were produced and tableted. The disintegration time was normalized to tablets of 2.5-megapascal tensile strength by interpolation. No significant dif- ferences in tablet tensile strength, friability, or normalized disintegra- tion time were observed between batches from the two roller dryers. The table below the figure shows the average values with a standard Figure 8 Tableting comparison for the six selected batches from each roller dryer that represent historical variation on tensile strength (left) and disintegration (right) Roller dryer Average value Tablet tensile strength @10kN Tablet tensile strength @15kN Friability @10kN Friability @15kN Disintegration time @2.5MPa 1 2.2±0.4 3.4±0.7 0.10±0.02% 0.06±0.04% 227±35 2 2.1±0.2 3.2±0.3 0.09±0.02% 0.06±0.01% 207±18 Roller dryer 1 Roller dryer 2 8 10 12 14 16 Tablet tensile strength (MPa) 6 5 4 3 2 1 0 Compaction force (kN) Roller dryer 1 Roller dryer 2 Disintegration time (min) 7 6 5 4 3 2 1 0 Tensile strength (MPa) 0 1 2 3 4 5 6 No significant differences in tablet tensile strength, friability, or normalized disintegration time were observed between batches from the two roller dryers.

Articles in this issue

Archives of this issue

view archives of Tablets & Capsules - TC0121